Quick Takeaways
- This page summarizes Linda M. Richardson's Form 4 filing for INTERCEPT PHARMACEUTICALS, INC..
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 16 Aug 2021, 19:00.
Linda M. Richardson - 15 Aug 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.
- Signature
- /s/ Mary J. Grendell, as attorney-in-fact
- Issuer symbol
- N/A
- Transactions as of
- 15 Aug 2021
- Net transactions value
- -$2,551
- Form type
- 4
- Filing time
- 16 Aug 2021, 19:00:44 UTC
- Previous filing
- 17 May 2021
- Next filing
- 03 Sep 2021
- SEC
- View on sec.gov
Quoteable Key Fact
"Linda M. Richardson filed Form 4 for INTERCEPT PHARMACEUTICALS, INC. on 16 Aug 2021."
What Changed
- Previous filing in this sequence was filed on 17 May 2021.
- Current net transaction value: -$2,551.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICPT | Common Stock | Tax liability | $2,551 | -171 | -0.64% | $14.92 | 26,524 | 15 Aug 2021 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person. |